Promising Modalities to Identify and Monitor Eosinophilic Esophagitis

Girish Hiremath, Sandeep Gupta

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Eosinophilic esophagitis (EoE) is an allergen-mediated condition characterized by symptoms of esophageal dysfunction and histologic evidence of intense eosinophilic inflammation involving the esophagus in the absence of overlapping conditions such as gastroesophageal reflux disease. Since the initial description as a distinct entity approximately 2 decades ago, there has been a remarkable increase in the recognition of this clinicopathologic entity. The current approach to diagnose and monitor EoE requires repeated esophagogastroduodenoscopies, with associated sedation/anesthesia, to visualize mucosal abnormalities, and to obtain multiple biopsy specimens for histologic assessment and to evaluate treatment response. Frequent esophagogastroduodenoscopies with multiple biopsies can increase the risk of procedural complications, place significant financial burden on families, and escalate health care costs. In addition, this burdensome approach may contribute toward delayed diagnosis and suboptimal monitoring, thereby increasing the likelihood of complications such as esophageal narrowing and stricture formation, which may require escalation of care including endoscopic interventions. Clinical progression and complications associated with EoE can be attenuated through early identification and optimal management. Therefore, developing reliable, safe, less-cumbersome, and cost-effective modalities for early diagnosis and effective monitoring of EoE is an area of active research. These efforts have been substantially supported by the development of new biomaterials, analytic methodologies, and the application of novel concepts. Herein, we summarize modalities that have shown promise to advance the diagnosis and monitoring of EoE and could improve the care of affected individuals and advance the field.

Original languageEnglish (US)
Pages (from-to)1655-1664
Number of pages10
JournalClinical Gastroenterology and Hepatology
Volume15
Issue number11
DOIs
StatePublished - Nov 1 2017
Externally publishedYes

Fingerprint

Eosinophilic Esophagitis
Digestive System Endoscopy
Biopsy
Esophageal Stenosis
Family Health
Delayed Diagnosis
Biocompatible Materials
Gastroesophageal Reflux
Health Care Costs
Allergens
Esophagus
Early Diagnosis
Anesthesia
Inflammation
Costs and Cost Analysis
Research

Keywords

  • Biomarkers
  • Diagnostics
  • Eosinophilic Esophagitis
  • Monitoring
  • Noninvasive Testing

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Promising Modalities to Identify and Monitor Eosinophilic Esophagitis. / Hiremath, Girish; Gupta, Sandeep.

In: Clinical Gastroenterology and Hepatology, Vol. 15, No. 11, 01.11.2017, p. 1655-1664.

Research output: Contribution to journalArticle

@article{fe41153954b240d2a24d1b3f1ee25690,
title = "Promising Modalities to Identify and Monitor Eosinophilic Esophagitis",
abstract = "Eosinophilic esophagitis (EoE) is an allergen-mediated condition characterized by symptoms of esophageal dysfunction and histologic evidence of intense eosinophilic inflammation involving the esophagus in the absence of overlapping conditions such as gastroesophageal reflux disease. Since the initial description as a distinct entity approximately 2 decades ago, there has been a remarkable increase in the recognition of this clinicopathologic entity. The current approach to diagnose and monitor EoE requires repeated esophagogastroduodenoscopies, with associated sedation/anesthesia, to visualize mucosal abnormalities, and to obtain multiple biopsy specimens for histologic assessment and to evaluate treatment response. Frequent esophagogastroduodenoscopies with multiple biopsies can increase the risk of procedural complications, place significant financial burden on families, and escalate health care costs. In addition, this burdensome approach may contribute toward delayed diagnosis and suboptimal monitoring, thereby increasing the likelihood of complications such as esophageal narrowing and stricture formation, which may require escalation of care including endoscopic interventions. Clinical progression and complications associated with EoE can be attenuated through early identification and optimal management. Therefore, developing reliable, safe, less-cumbersome, and cost-effective modalities for early diagnosis and effective monitoring of EoE is an area of active research. These efforts have been substantially supported by the development of new biomaterials, analytic methodologies, and the application of novel concepts. Herein, we summarize modalities that have shown promise to advance the diagnosis and monitoring of EoE and could improve the care of affected individuals and advance the field.",
keywords = "Biomarkers, Diagnostics, Eosinophilic Esophagitis, Monitoring, Noninvasive Testing",
author = "Girish Hiremath and Sandeep Gupta",
year = "2017",
month = "11",
day = "1",
doi = "10.1016/j.cgh.2017.05.004",
language = "English (US)",
volume = "15",
pages = "1655--1664",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "11",

}

TY - JOUR

T1 - Promising Modalities to Identify and Monitor Eosinophilic Esophagitis

AU - Hiremath, Girish

AU - Gupta, Sandeep

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Eosinophilic esophagitis (EoE) is an allergen-mediated condition characterized by symptoms of esophageal dysfunction and histologic evidence of intense eosinophilic inflammation involving the esophagus in the absence of overlapping conditions such as gastroesophageal reflux disease. Since the initial description as a distinct entity approximately 2 decades ago, there has been a remarkable increase in the recognition of this clinicopathologic entity. The current approach to diagnose and monitor EoE requires repeated esophagogastroduodenoscopies, with associated sedation/anesthesia, to visualize mucosal abnormalities, and to obtain multiple biopsy specimens for histologic assessment and to evaluate treatment response. Frequent esophagogastroduodenoscopies with multiple biopsies can increase the risk of procedural complications, place significant financial burden on families, and escalate health care costs. In addition, this burdensome approach may contribute toward delayed diagnosis and suboptimal monitoring, thereby increasing the likelihood of complications such as esophageal narrowing and stricture formation, which may require escalation of care including endoscopic interventions. Clinical progression and complications associated with EoE can be attenuated through early identification and optimal management. Therefore, developing reliable, safe, less-cumbersome, and cost-effective modalities for early diagnosis and effective monitoring of EoE is an area of active research. These efforts have been substantially supported by the development of new biomaterials, analytic methodologies, and the application of novel concepts. Herein, we summarize modalities that have shown promise to advance the diagnosis and monitoring of EoE and could improve the care of affected individuals and advance the field.

AB - Eosinophilic esophagitis (EoE) is an allergen-mediated condition characterized by symptoms of esophageal dysfunction and histologic evidence of intense eosinophilic inflammation involving the esophagus in the absence of overlapping conditions such as gastroesophageal reflux disease. Since the initial description as a distinct entity approximately 2 decades ago, there has been a remarkable increase in the recognition of this clinicopathologic entity. The current approach to diagnose and monitor EoE requires repeated esophagogastroduodenoscopies, with associated sedation/anesthesia, to visualize mucosal abnormalities, and to obtain multiple biopsy specimens for histologic assessment and to evaluate treatment response. Frequent esophagogastroduodenoscopies with multiple biopsies can increase the risk of procedural complications, place significant financial burden on families, and escalate health care costs. In addition, this burdensome approach may contribute toward delayed diagnosis and suboptimal monitoring, thereby increasing the likelihood of complications such as esophageal narrowing and stricture formation, which may require escalation of care including endoscopic interventions. Clinical progression and complications associated with EoE can be attenuated through early identification and optimal management. Therefore, developing reliable, safe, less-cumbersome, and cost-effective modalities for early diagnosis and effective monitoring of EoE is an area of active research. These efforts have been substantially supported by the development of new biomaterials, analytic methodologies, and the application of novel concepts. Herein, we summarize modalities that have shown promise to advance the diagnosis and monitoring of EoE and could improve the care of affected individuals and advance the field.

KW - Biomarkers

KW - Diagnostics

KW - Eosinophilic Esophagitis

KW - Monitoring

KW - Noninvasive Testing

UR - http://www.scopus.com/inward/record.url?scp=85042181264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042181264&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2017.05.004

DO - 10.1016/j.cgh.2017.05.004

M3 - Article

C2 - 28501533

AN - SCOPUS:85042181264

VL - 15

SP - 1655

EP - 1664

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 11

ER -